Literature DB >> 25048877

Alteration of vascular reactivity in heart failure: role of phosphodiesterases 3 and 4.

F Hubert1, M Belacel-Ouari, B Manoury, K Zhai, V Domergue-Dupont, P Mateo, F Joubert, R Fischmeister, V Leblais.   

Abstract

BACKGROUND AND
PURPOSE: This study examined the role of the main vascular cAMP-hydrolysing phosphodiesterases (cAMP-PDE) in the regulation of basal vascular tone and relaxation of rat aorta mediated by β-adrenoceptors, following heart failure (HF). EXPERIMENTAL APPROACH: Twenty-two weeks after proximal aortic stenosis, to induce HF, or SHAM surgery in rats, we evaluated the expression, activity and function of cAMP-PDE in the descending thoracic aorta. KEY
RESULTS: HF rat aortas exhibited signs of endothelial dysfunction, with alterations of the NO pathway, and alteration of PDE3 and PDE4 subtype expression, without changing total aortic cAMP-hydrolytic activity and PDE1, PDE3 and PDE4 activities. Vascular reactivity experiments using PDE inhibitors showed that PDE3 and PDE4 controlled the level of PGF2α -stimulated contraction in SHAM aorta. PDE3 function was partially inhibited by endothelial NO, whereas PDE4 function required a functional endothelium and was under the negative control of PDE3. In HF, PDE3 function was preserved, but its regulation by endothelial NO was altered. PDE4 function was abolished and restored by PDE3 inhibition. In PGF2α -precontracted arteries, β-adrenoceptor stimulation-induced relaxation in SHAM aorta, which was abolished in the absence of functional endothelium, as well as in HF aortas, but restored after PDE3 inhibition in all unresponsive arteries. CONCLUSIONS AND IMPLICATIONS: Our study underlines the key role of the endothelium in controlling the contribution of smooth muscle PDE to contractile function. In HF, endothelial dysfunction had a major effect on PDE3 function and PDE3 inhibition restored a functional relaxation to β-adrenoceptor stimulation.
© 2014 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25048877      PMCID: PMC4294045          DOI: 10.1111/bph.12853

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  45 in total

1.  Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity.

Authors:  T Sudo; K Tachibana; K Toga; S Tochizawa; Y Inoue; Y Kimura; H Hidaka
Journal:  Biochem Pharmacol       Date:  2000-02-15       Impact factor: 5.858

2.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

3.  Enhanced activities and gene expression of phosphodiesterase types 3 and 4 in pressure-induced congestive heart failure.

Authors:  Koki Takahashi; Tomohiro Osanai; Takao Nakano; Makoto Wakui; Ken Okumura
Journal:  Heart Vessels       Date:  2002-09       Impact factor: 2.037

4.  Blunted peripheral vasodilatory response is a hallmark of progressive deterioration in mild to moderate congestive heart failure.

Authors:  M Nakamura; N Arakawa; H Yoshida; S Saitoh; H Kon; K Hiramori
Journal:  J Card Fail       Date:  2001-03       Impact factor: 5.712

5.  In vivo assessment of local phosphodiesterase activity using tailored cyclic nucleotide-gated channels as cAMP sensors.

Authors:  T C Rich; T E Tse; J G Rohan; J Schaack; J W Karpen
Journal:  J Gen Physiol       Date:  2001-07       Impact factor: 4.086

Review 6.  Animal models of chronic heart failure.

Authors:  F Muders; D Elsner
Journal:  Pharmacol Res       Date:  2000-06       Impact factor: 7.658

7.  Vascular beta-adrenergic receptor system is dysfunctional after myocardial infarction.

Authors:  M A Gaballa; A Eckhart; W J Koch; S Goldman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-03       Impact factor: 4.733

8.  Left ventricular hypertrophy induced by aortic banding impairs relaxation of isolated coronary arteries.

Authors:  Rory B McGoldrick; Martyn Kingsbury; Mark A Turner; Desmond J Sheridan; Alun D Hughes
Journal:  Clin Sci (Lond)       Date:  2007-12       Impact factor: 6.124

9.  The Concise Guide to PHARMACOLOGY 2013/14: enzymes.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

10.  The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands.

Authors:  Adam J Pawson; Joanna L Sharman; Helen E Benson; Elena Faccenda; Stephen P H Alexander; O Peter Buneman; Anthony P Davenport; John C McGrath; John A Peters; Christopher Southan; Michael Spedding; Wenyuan Yu; Anthony J Harmar
Journal:  Nucleic Acids Res       Date:  2013-11-14       Impact factor: 16.971

View more
  6 in total

1.  Cyclic nucleotide signalling compartmentation by PDEs in cultured vascular smooth muscle cells.

Authors:  Liang Zhang; Kaouter Bouadjel; Boris Manoury; Grégoire Vandecasteele; Rodolphe Fischmeister; Véronique Leblais
Journal:  Br J Pharmacol       Date:  2019-04-24       Impact factor: 8.739

2.  The Use of Wire Myography to Investigate Vascular Tone and Function.

Authors:  Kayleigh Griffiths; Melanie Madhani
Journal:  Methods Mol Biol       Date:  2022

3.  A cardiac mitochondrial cAMP signaling pathway regulates calcium accumulation, permeability transition and cell death.

Authors:  Z Wang; D Liu; A Varin; V Nicolas; D Courilleau; P Mateo; C Caubere; P Rouet; A-M Gomez; G Vandecasteele; R Fischmeister; C Brenner
Journal:  Cell Death Dis       Date:  2016-04-21       Impact factor: 8.469

4.  Activation of bitter taste receptors (tas2rs) relaxes detrusor smooth muscle and suppresses overactive bladder symptoms.

Authors:  Kui Zhai; Zhiguang Yang; Xiaofei Zhu; Eric Nyirimigabo; Yue Mi; Yan Wang; Qinghua Liu; Libo Man; Shiliang Wu; Jie Jin; Guangju Ji
Journal:  Oncotarget       Date:  2016-04-19

5.  Rosmarinic acid suppresses adipogenesis, lipolysis in 3T3-L1 adipocytes, lipopolysaccharide-stimulated tumor necrosis factor-α secretion in macrophages, and inflammatory mediators in 3T3-L1 adipocytes.

Authors:  Yehua Rui; Lingxia Tong; Jinbo Cheng; Guiping Wang; Liqiang Qin; Zhongxiao Wan
Journal:  Food Nutr Res       Date:  2017-06-07       Impact factor: 3.894

Review 6.  PDE-Mediated Cyclic Nucleotide Compartmentation in Vascular Smooth Muscle Cells: From Basic to a Clinical Perspective.

Authors:  Margarida Lorigo; Nelson Oliveira; Elisa Cairrao
Journal:  J Cardiovasc Dev Dis       Date:  2021-12-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.